In vitro susceptibility of Nocardia spp. to a new fluoroquinolone, tosufloxacin (T-3262)
- 1 December 1989
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (12) , 2140-2141
- https://doi.org/10.1128/aac.33.12.2140
Abstract
The in vitro activity of a new fluoroquinolone, tosufloxacin (T-3262), against 111 pathogenic Nocardia strains was studied by an agar dilution method and compared with the activities of other fluoroquinolones. All strains were susceptible to tosufloxacin, and the drug was 2 to 20 times more active than four other quinolones tested. Nocardia farcinica was the Nocardia species most susceptible to tosufloxacin.This publication has 10 references indexed in Scilit:
- In vitro susceptibilities of Nocardia species to newer antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1988
- Susceptibility of Nocardia asteroides to new quinolones and beta-lactamsAntimicrobial Agents and Chemotherapy, 1987
- Lymphocutaneous nocardiosis caused by Nocardia asteroides. Case report and literature reviewArchives of Dermatology, 1986
- Therapy of experimental cerebral nocardiosis with imipenem, amikacin, trimethoprim-sulfamethoxazole, and minocyclineAntimicrobial Agents and Chemotherapy, 1986
- The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroAntimicrobial Agents and Chemotherapy, 1985
- THERAPEUTIC EFFECT OF A NEW ANTIBACTERIAL SUBSTANCE OFLOXACIN (DL8280) ON PULMONARY TUBERCULOSISPublished by Elsevier ,1985
- Trimethoprim/sulfamethoxazole-resistant nocardia asteroides causing multiple hepatic abscesses: Successful treatment with ampicillin, amikacin, and limited computed tomography-guided needle aspirationThe American Journal of Medicine, 1984
- Numerical Analysis of the Taxonomy of Nocardiae and RhodococciMicrobiology and Immunology, 1982
- Nocardial Infections in the United States, 1972-1974The Journal of Infectious Diseases, 1976